Financial Data and Key Metrics Changes - In Q2 2024, net sales reached $40.4 million, slightly above the top-end of guidance, but down 4.3% year-over-year [18] - Volume decreased by 5.9%, reflecting challenges in on-shelf distribution, partially offset by a price increase contributing $2.4 million [18] - Gross margin was 41.9%, down 4.7 percentage points from the previous year, impacted by a €1.8 million charge related to excess inventory [16][18] - Net loss increased to $7 million compared to a net loss of $5 million last year, with adjusted EBITDA loss at $4.4 million [19] Business Line Data and Key Metrics Changes - Strong performance in the food channel, with 16% growth over 12 weeks and 20% growth over the last 4-week period [9] - New product launches, including Cran-Raspberry, are expected to drive incremental growth [8][15] - The company implemented a 4.5% price increase on soda multipacks, which was well-received by retailers and consumers [9] Market Data and Key Metrics Changes - Zevia soda scan dollars were up 6% for the 12 weeks ending July 14, with units up 2% [8] - Retail sales growth accelerated, with dollars closing at +10% and units at +11% in the latest 4-week period, marking the highest retail sales month in Zevia's history [8] - The company is seeing promising growth in strategic channels, particularly in food, which outpaced the broader Carbonated Soft Drinks category [9][23] Company Strategy and Development Direction - The company is focused on enhancing brand visibility and expanding distribution through direct-store delivery (DSD) initiatives [10][14] - A productivity initiative aims for annualized savings of $12 million, targeting brand maximization, margin enhancement, and operational discipline [12][13] - The strategic focus includes increasing marketing investments to drive consumer awareness and trial packages to expand the user base [10][28] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about retail sales growth despite challenges in club distribution, expecting improvements in Q4 [32] - The promotional environment is competitive, with increased promotional spending planned to drive in-store activity [35] - Management anticipates a return to mid-40s gross margins in Q3, with sequential improvements expected [21][41] Other Important Information - The company ended the quarter with approximately $29 million in cash and cash equivalents, alongside an undrawn revolving credit line of $20 million [19] - The company is committed to maintaining a right-sized inventory level, targeting around 90 days of inventory on hand [45] Q&A Session Summary Question: Impact of club distribution losses - Management acknowledged regional losses in club distribution but noted strong retail scan data and overall healthy retail performance [26] Question: Strategies for reaching new consumers without club visibility - The focus is on expanding singles distribution to drive trial packages in various channels, including mainstream grocery and convenience [28] Question: Clarification on Q3 revenue guidance - Management explained that Q3 guidance reflects temporary distribution challenges and a focus on optimizing the product portfolio [32][33] Question: Promotional environment insights - The promotional environment is competitive, with deeper promotions observed, but the company plans to increase promotional investments to drive growth [35] Question: Marketing efficacy and metro outperformance - Marketing campaigns across multiple markets have shown a 3 percentage point improvement in revenue, indicating effective strategic planning [39] Question: Future gross margin potential - Management expects to maintain mid-40s gross margins while reinvesting in promotional activities and expanding the DSD network [41] Question: Inventory management going forward - The company aims to maintain inventory levels close to current levels while managing working capital effectively [45]

Company Performance - Zevia reported a quarterly loss of $0.09 per share, better than the Zacks Consensus Estimate of a loss of $0.13, and compared to a loss of $0.08 per share a year ago, indicating an earnings surprise of 30.77% [1] - The company posted revenues of $40.43 million for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 2.13%, but down from $42.24 million in the same quarter last year [2] - Over the last four quarters, Zevia has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Zevia shares have declined approximately 55.2% since the beginning of the year, contrasting with the S&P 500's gain of 9.9% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.10 on revenues of $44.85 million, and for the current fiscal year, it is -$0.37 on revenues of $163.17 million [7] Industry Outlook - The Medical - Products industry, to which Zevia belongs, is currently ranked in the top 42% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Zevia's stock performance [5]

Zevia PBC (NYSE:ZVIA) Q1 2024 Earnings Conference Call May 8, 2024 8:30 AM ET Company Participants Reed Anderson - Managing Director, Investor Relations Amy Taylor - President & Chief Executive Officer Girish Satya - Chief Financial Officer Conference Call Participants Bonnie Herzog - Goldman Sachs Jim Salera - Stephens Inc. Eric Serotta - Morgan Stanley Sarang Vora - Telsey Advisory Group Operator Good day ladies and gentlemen and welcome to Zevia PBC Q1 2024 Earnings Call. [Operator Instructions] Please n ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40630 Zevia PBC (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organiz ...

Financial Performance - Net sales for the year ended December 31, 2023, were $166.4 million, a 2.0% increase from $163.2 million in 2022[248]. - The net loss attributable to Zevia PBC was $21.5 million in 2023, an improvement from a net loss of $33.9 million in 2022[246]. - Adjusted EBITDA for 2023 was $(19,049) thousand, compared to $(19,641) thousand in 2022, indicating a slight improvement year-over-year[283]. - The net loss for 2023 was $(28,322) thousand, a decrease from $(47,647) thousand in 2022, reflecting a reduction in overall losses[283]. Sales and Marketing - The number of equivalized cases sold decreased to 12.7 million in 2023 from 13.6 million in 2022, primarily due to supply chain logistics challenges[248]. - Selling and marketing expenses rose to $62.3 million in 2023, up from $52.9 million in 2022, reflecting increased warehousing and distribution costs[246]. - Selling and marketing expenses rose to $62.3 million in 2023, up $9.4 million or 17.9% from $52.9 million in 2022, mainly due to higher freight transfer and warehousing costs[252]. Cost Management - Cost of goods sold decreased by $1.5 million, or 1.6%, to $91.7 million in 2023, attributed to a 6.9% decrease in shipments and higher inventory losses[249]. - General and administrative expenses decreased to $31.5 million in 2023 from $36.8 million in 2022, while remaining a smaller percentage of net sales[246][247]. - General and administrative expenses decreased to $31.5 million in 2023, down $5.3 million or 14.4% from $36.8 million in 2022, driven by reduced employee-related costs and cost productivity initiatives[253]. - Equity-based compensation expense significantly decreased to $8.3 million in 2023, down $18.6 million or 69.2% from $26.9 million in 2022, primarily due to changes in equity award vesting[254]. Profitability - Gross profit increased to $74.8 million in 2023, up from $70.0 million in 2022, resulting in a gross margin of 45% compared to 43% in the previous year[246][247]. - Gross profit for the year ended December 31, 2023, was $74.8 million, an increase of $4.7 million or 6.8% from $70.0 million in 2022, primarily driven by pricing increases[250]. - Gross margin improved to 44.9% in 2023 from 42.9% in 2022, attributed to pricing increases, partially offset by higher inventory losses[251]. Liquidity and Capital Resources - As of December 31, 2023, the company had $32.0 million in cash and cash equivalents, which, along with operating activities and available borrowings, is expected to provide adequate liquidity for ongoing operations[258]. - Net cash used in operating activities was $16.3 million in 2023, influenced by a net loss of $28.3 million, partially offset by non-cash expenses and changes in operating assets and liabilities[273]. - Future capital requirements will depend on revenue growth, gross margin, and expenditures, with potential needs for additional financing if existing resources are insufficient[260]. - The company had a revolving credit facility with a commitment of $20 million, with no amounts drawn as of December 31, 2023[267]. Supply Chain and Manufacturing - A strategic change in manufacturing will take effect in Q1 2024, with contract manufacturers responsible for raw material procurement, aimed at optimizing the supply chain[230]. - The brand refresh initiative included a new logo and discontinuation of selected SKUs to focus on high-potential products[229]. - The Company has entered into a two-year agreement effective October 15, 2023, with a supplier for stevia extract, which includes fixed pricing[306]. - The Company is diversifying its sources of supply for raw materials to mitigate potential supply disruptions, although there is no assurance of securing alternative sources[306]. Tax and Deferred Tax Assets - As of December 31, 2023, the company has a full valuation allowance against deferred tax assets totaling $75.5 million, indicating potential challenges in realizing these tax benefits[295]. - The company did not record any unrecognized tax benefits as of December 31, 2023, indicating no significant tax disputes or uncertainties[297]. - As of December 31, 2023, the Company has not recorded a liability related to the tax savings from its Deferred Tax Assets (DTAs) subject to the TRA, as it is more likely than not that these DTAs will not be realized[303]. - The TRA liability, if the associated tax benefits were fully realizable, would total $56.2 million as of December 31, 2023, up from $55.8 million in 2022, primarily due to Class B to Class A exchanges[303]. Economic and Market Conditions - The company expects continued inflationary pressures to impact operating costs and margins into 2024[231]. - Inflation has had a material effect on the Company's business, and further significant inflationary pressures could harm its financial condition[310]. - The Company is subject to commodity risks related to purchases of aluminum, diesel fuel, cartons, and corrugate, which may limit its ability to recover increased costs through higher pricing[311]. - Foreign exchange gains and losses were not material for the years ended December 31, 2023, and 2022, as the majority of sales and costs are in U.S. dollars[309].

Zevia ZEUIA ZeyIa ream Soda Zevil k Cherry Zeula revil Zevil Leuil levia 4 GEUI8 Zeula 1 2023 Financial Results 12 FL OZ (355) Safe Harbor Statement This presentation and the related earnings press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievemen ...

Zevia PBC (NYSE:ZVIA) Q4 2023 Earnings Conference Call February 27, 2024 8:30 AM ET Company Participants Reed Anderson - Managing Director, Investor Relations Amy Taylor - President and CEO Girish Satya - Chief Financial Officer Florence Neubauer - Senior Vice President, Finance and Business Transformation Conference Call Participants Ethan Huntley - Goldman Sachs Andrew Strelzik - BMO Capital Markets Sarang Vora - Telsey Advisory Group Jim Salera - Stephens Operator Ladies and gentlemen, good morning. And ...

Zevia Announces Fourth Quarter and Full Year 2023 Results Q4 Net Sales up 6.9%, including unit volumes up 3.7% Exhibit 99.1 LOS ANGELES – February 27, 2024 (BUSINESS WIRE) – Zevia PBC ("Zevia" or the "Company") (NYSE: ZVIA), the company bringing great tasting, zero sugar beverages made with simple, plant-based ingredients across usage occasions today reported results for the fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Highlights Full Year 2023 Highlights "Our fourth quarter v ...

Zevia PBC (NYSE:ZVIA) Q3 2023 Earnings Conference Call November 7, 2023 8:08 AM ET Company Participants Reed Anderson - Managing Director ICR Amy Taylor - President & Chief Executive Officer Florence Neubauer - Interim Chief Financial Officer Conference Call Participants Bonnie Herzog - Goldman Sachs Jim Salera - Stephens Chris Carey - Wells Fargo Securities Dana Telsey - Telsey Advisory Daniel Gold - Bank of Montreal Alton Stump - Loop Capital Markets Operator Greetings and welcome to Zevia PBC Q3 2023 ear ...

| --- | --- | --- | --- | --- | |----------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | Peach | | | | | | Sweetened Black Tea Naturally Flavored 12 FL OZ (355 mL) | | | | | Q3 2023 Financial Results ZEUIA Safe Harbor Statement This presentation and the related earnings press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act o ...